Soleno Therapeutics (SLNO) Drops Amid Critical Scorpion Report — Hagens Berman
(NASDAQ:SLNO), SAN FRANCISCO, Aug. 19, 2025 (GLOBE NEWSWIRE) — On August 15, 2025, shares in Soleno Therapeutics, Inc. (NASDAQ: SLNO) experienced a significant drop following the release of a highly critical report by Scorpion Capital. Hagens Berman, a national shareholders rights firm, has opened an investigation into Soleno. The firm will investigate whether Soleno may […]